Zomedica (ZOMDF) Non-Current Deffered Revenue (2021 - 2026)
Zomedica's Non-Current Deffered Revenue came in at $294,000 for Q2 2026, up 10.1% from $267,000 a year earlier and up 7.7% from the prior quarter.
Powered by 
Analysis
Zomedica (ZOMDF) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends
At the end of FY2025, Zomedica's Non-Current Deffered Revenue was $232,000, up 5.9% from FY2024.
- Non-Current Deffered Revenue carries a four-year compound annual growth rate of 13.5% (FY2021 to FY2025).
- Going back by year, Non-Current Deffered Revenue was $219,000 in FY2024 (-13.1%), $252,000 in FY2023 (+38.5%), $182,000 in FY2022 (+30.0%) and $140,000 in FY2021.
- The Q2 2026 figure represents the highest quarterly Non-Current Deffered Revenue in data going back to Q4 2021.
- Year-over-year, Non-Current Deffered Revenue has increased for three consecutive quarters, with an average decline of 2.1% over the last eight quarters.
- The fastest year-over-year change in Non-Current Deffered Revenue over five years came in Q2 2023 (growth of 80.7%), and the weakest in Q4 2024 (a decline of 13.1%).
- Business Quant data shows ZOMDF's Non-Current Deffered Revenue at $273,000 (Q1 2026), $232,000 (Q4 2025) and $236,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,142.35 Bn | 1,110.94 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.52 Bn | 555.38 Bn | 17.30 Bn | - |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | - |
| 4 | Merck | 356.35 Bn | 310.72 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 300.53 Bn | 264.52 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 263.02 Bn | 236.71 Bn | 12.86 Bn | - |
| 7 | Amgen | 238.00 Bn | 193.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.35 Bn | 168.55 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.37 Bn | 117.02 Bn | 10.94 Bn | - |
| 10 | Zomedica | 78.40 Mn | -119.63 Mn | 6.04 Mn | 294,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 294,000.00 |
| Mar 31, 2026 | 273,000.00 |
| Dec 31, 2025 | 232,000.00 |
| Sep 30, 2025 | 236,000.00 |
| Jun 30, 2025 | 267,000.00 |
| Mar 31, 2025 | 251,000.00 |
| Dec 31, 2024 | 219,000.00 |
| Sep 30, 2024 | 260,000.00 |
| Jun 30, 2024 | 282,000.00 |
| Mar 31, 2024 | 279,000.00 |
| Dec 31, 2023 | 252,000.00 |
| Sep 30, 2023 | 270,000.00 |
| Jun 30, 2023 | 291,000.00 |
| Mar 31, 2023 | 263,000.00 |
| Dec 31, 2022 | 182,000.00 |
| Sep 30, 2022 | 213,000.00 |
| Jun 30, 2022 | 161,000.00 |
| Mar 31, 2022 | 155,000.00 |
| Dec 31, 2021 | 140,000.00 |
API Access
Zomedica Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ZOMDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ZOMDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();